Early Oral Hydration After Thoracoscopic Surgery

February 29, 2024 updated by: Chang Gung Memorial Hospital

Safety and Feasibility of Early Oral Hydration After Video-assisted Thoracoscopic Surgery: A Prospective, Randomized, and Controlled Study

The goal of this clinical trial is to learn about the safety and feasibility of early oral hydration in patients receiving video-assisted thoracoscopic surgery after general anesthesia. The main questions aims to answer:

  • the safety and feasibility of oral hydration supplementation in the recovery room following general anesthesia.
  • the degree of improvement in sore throat and dry mouth after oral hydration.
  • the side effects and risks of oral hydration supplementation, such as the incidence of postoperative nausea and vomiting.
  • the impact of oral hydration supplementation in the recovery room following general anesthesia on hemodynamics.
  • patient satisfaction with oral hydration supplementation in the recovery room following general anesthesia.

Participants will receive a series of oral hydration from swab moistening, and ice cube hydration to water hydration in the recovery room. Researchers will compare with the standard, no-hydration group to see if it is safe and feasible to hydrate patients in the recovery room.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Anesthesiologists assess the removal of the endotracheal tube post-surgery and the patient is then transferred to the recovery room for rest. The principal investigator will evaluate the consciousness status and risk of nausea and vomiting to confirm eligibility for the trial. Subsequently, the following grouping will be conducted:

  1. Experimental group

    • First, moisten the patient's throat with a cotton swab dipped in water. If no nausea or vomiting occurs after five minutes, proceed to the next stage.
    • Provide an ice cube for the patient to hold in their mouth. If no nausea or vomiting occurs after ten minutes, proceed to the next stage.
    • Offer 10-20ml water for the patient to drink under medical supervision. If no nausea or vomiting occurs and the patient requests more water, administer 10-20ml of water every ten minutes, assessing for any adverse effects each time. The total water intake should not exceed 500ml.
  2. Comparison group - standard care without any intervention

Evaluate the level of throat pain using VAS (Visual Analogue Scale) score, the incidence, timing, frequency of post-operative nausea and vomiting, the level of mouth dryness, the satisfaction of patients in recovery room, and the vital signs.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taoyuan, Taiwan, 33380
        • ChangGung MH
        • Contact:
          • JUN-YU CHEN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Males and females aged 18 to 70.
  • Anesthesia physical status classification III or below
  • Body Mass Index 30 or below
  • Elective video-assisted thoracoscopic surgery

Exclusion Criteria:

  • Pre-operative throat pain
  • Impaired mental status
  • Tendency to choke (inc. dysphagia, stroke hx.)
  • Nil Per Os (NPO) less than 8 hours
  • Pregnancy
  • Nausea and vomiting in Operating room or Post-anesthesia care unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oral hydration
wet swab-ice cube-small amount of water
  • Researchers moisten the patient's throat with a wet cotton swab. If no nausea or vomiting occurs after five minutes, proceed to the next stage.
  • Provide an ice cube of potable water for the patient to hold in their mouth. If no nausea or vomiting occurs after ten minutes, proceed to the next stage.
  • Offer 10-20ml of potable water for the patient to drink under medical supervision. If no nausea or vomiting occurs and the patient requests more water, administer 10-20ml every ten minutes, assessing for any adverse effects each time. The total water intake should not exceed 500ml.
No Intervention: No hydration
According to routine care, no oral fluid supplementation is provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sore throat level by VAS (Visual Analogue Scale)
Time Frame: From patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hours
sore throat level by VAS (Visual Analogue Scale) measured by 0-10 point-scale
From patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hours
Mouth dryness
Time Frame: From patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hours
Modified Schirmer tear strip test
From patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post-operative nausea and vomiting (PONV)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
PONV exist or not
From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
timing of post-operative nausea and vomiting (PONV)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
PONV or not, if yes, record timing
From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
duration of post-operative nausea and vomiting (PONV)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
PONV or not, if yes, record duration
From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
management of post-operative nausea and vomiting (PONV)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
PONV or not, if yes, record management
From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hours
Heart Rate in PACU (Postanesthesia Care Unit)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hours
Heart Rate (/min) in PACU (Postanesthesia Care Unit)
From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hours
Blood pressure in PACU (Postanesthesia Care Unit)
Time Frame: From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hours
Blood pressure (mmHg) in PACU (Postanesthesia Care Unit)
From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hours
Patient's satisfaction
Time Frame: Through study completion, before patients leaving PACU (Postanesthesia Care Unit)
Patient's satisfaction measured by Likert scale (1-5)
Through study completion, before patients leaving PACU (Postanesthesia Care Unit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: JUN-YU CHEN, +886937020809

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

February 5, 2024

First Submitted That Met QC Criteria

February 29, 2024

First Posted (Actual)

March 7, 2024

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

February 29, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2401110013

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Oral hydration

Subscribe